Following discussions with Vertex recently, CFI are delighted to share the news that today Vertex and the Health Service Executive (HSE) have signed an extension to the current CFTR modulator portfolio agreement for one additional year.

This extension ensures continued access to these life-changing medicines for people with Cystic Fibrosis in Ireland. CFI welcomes this positive development and appreciates the ongoing collaboration between Vertex and the HSE in supporting the CF community.